Holen Sie sich die Stockscreener-App
3.88
1.66%
0.02
Schlusskurs vom Vortag:
$3.86
Offen:
$3.86
24-Stunden-Volumen:
6,262
Relative Volume:
0.02
Marktkapitalisierung:
$6.19M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-14.58M
KGV:
-3.3739
EPS:
-1.15
Netto-Cashflow:
$-9.80M
1W Leistung:
-15.06%
1M Leistung:
-22.91%
6M Leistung:
-68.98%
1J Leistung:
-90.79%
1-Tages-Spanne:
$3.86
$3.94
1-Wochen-Bereich:
$3.83
$4.7606
52-Wochen-Spanne:
$3.80
$44.00
Acurx Pharmaceuticals Inc Stock (ACXP) Company Profile
Firmenname
Acurx Pharmaceuticals Inc
Sektor
Branche
Telefon
917-533-1469
Adresse
259 LIBERTY AVENUE, STATEN ISLAND
Vergleichen Sie ACXP mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ACXP
Acurx Pharmaceuticals Inc
|
3.905 | 6.12M | 0 | -14.58M | -9.80M | -1.15 |
|
VRTX
Vertex Pharmaceuticals Inc
|
401.09 | 101.77B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
449.51 | 59.45B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
572.62 | 60.12B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
746.02 | 44.90B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
336.78 | 35.07B | 3.81B | -644.79M | -669.77M | -6.24 |
Acurx Pharmaceuticals Inc Aktie (ACXP) Neueste Nachrichten
What MACD signals say about Acurx Pharmaceuticals Inc.2025 Risk Factors & Growth-Oriented Investment Plans - Newser
Is Acurx Pharmaceuticals Inc. stock undervalued right nowJuly 2025 Highlights & Long-Term Capital Growth Strategies - 더경남뉴스
Signal strength of Acurx Pharmaceuticals Inc. stock in tech scanners2025 Growth vs Value & Risk Managed Investment Entry Signals - Newser
Trend analysis for Acurx Pharmaceuticals Inc. this weekMarket Trend Review & Real-Time Market Sentiment Reports - Newser
Analyzing recovery setups for Acurx Pharmaceuticals Inc. investorsQuarterly Risk Review & Expert Verified Movement Alerts - Newser
Is Acurx Pharmaceuticals Inc. stock poised for growthEarnings Performance Report & Real-Time Stock Entry Alerts - Newser
What does recent volatility data suggest for Acurx Pharmaceuticals Inc.Swing Trade & Reliable Intraday Trade Plans - Newser
Is Acurx Pharmaceuticals Inc. forming a bullish divergenceMarket Trend Report & Entry and Exit Point Strategies - khodrobank.com
Technical analysis overview for Acurx Pharmaceuticals Inc. stock2025 Investor Takeaways & Weekly Momentum Picks - Newser
Will Acurx Pharmaceuticals Inc. rebound enough to break evenJuly 2025 Sector Moves & Stepwise Entry/Exit Trade Alerts - Newser
Will Acurx Pharmaceuticals Inc. stock recover after recent dropJuly 2025 Levels & Weekly Momentum Stock Picks - Newser
Does Acurx Pharmaceuticals Inc. fit your quant trading modelJuly 2025 Review & Technical Analysis for Trade Confirmation - Newser
Acurx Pharmaceuticals Inc. stock momentum explained2025 Trading Recap & Weekly Watchlist for Hot Stocks - Newser
Will Acurx Pharmaceuticals Inc. outperform the market in YEAR2025 Market Outlook & Weekly Watchlist of Top Performers - khodrobank.com
Can Acurx Pharmaceuticals Inc. keep up with sector leadersJuly 2025 Summary & Verified Chart Pattern Signals - khodrobank.com
Will a bounce in Acurx Pharmaceuticals Inc. offer an exitWeekly Trade Analysis & Technical Buy Zone Confirmations - Newser
Acurx Pharmaceuticals Meets Nasdaq Listing Requirements - AInvest
Is Acurx Pharmaceuticals Inc. stock technically oversoldBuy Signal & Weekly Momentum Stock Picks - khodrobank.com
What’s next for Acurx Pharmaceuticals Inc. stock price2025 Retail Activity & Risk Controlled Daily Trade Plans - Newser
Short interest data insights for Acurx Pharmaceuticals Inc.Treasury Yields & Fast Entry Momentum Trade Alerts - Newser
Acurx Pharmaceuticals Reaches Nasdaq Compliance and Maintains Listing. - AInvest
Acurx pharmaceuticals regains compliance with Nasdaq listing rules - Investing.com
Applying sector rotation models to Acurx Pharmaceuticals Inc.July 2025 Chart Watch & Free Weekly Chart Analysis and Trade Guides - Newser
Biotech Acurx Pharmaceuticals Secures Future on Nasdaq by Meeting Critical $1 Bid, $2.5M Equity Rules - Stock Titan
Will Acurx Pharmaceuticals Inc. outperform the marketGlobal Markets & Expert Curated Trade Setup Alerts - Newser
Automated trading signals detected on Acurx Pharmaceuticals Inc.Portfolio Return Report & Free Technical Confirmation Trade Alerts - Newser
What data driven models say about Acurx Pharmaceuticals Inc.’s future2025 Market WrapUp & Risk Controlled Daily Plans - Newser
How to integrate Acurx Pharmaceuticals Inc. into portfolio analysis tools2025 EndofYear Setup & Community Consensus Stock Picks - Newser
Real time pattern detection on Acurx Pharmaceuticals Inc. stock2025 Volatility Report & Growth Focused Entry Point Reports - Newser
Stock Report: What is Acurx Pharmaceuticals Inc.’s valuation compared to sectorMarket Sentiment Report & Verified Technical Signals - khodrobank.com
Published on: 2025-09-02 13:24:12 - Newser
Visual trend scoring systems applied to Acurx Pharmaceuticals Inc.Trade Signal Summary & Daily Chart Pattern Signal Reports - Newser
Using AI based signals to follow Acurx Pharmaceuticals Inc.Layoff News & Daily Growth Stock Investment Tips - Newser
Will Acurx Pharmaceuticals Inc. benefit from macro trendsJuly 2025 Short Interest & AI Powered Buy/Sell Recommendations - Newser
Can Acurx Pharmaceuticals Inc. weather a recessionTrade Risk Summary & Daily Oversold Stock Bounce Ideas - khodrobank.com
Using R and stats models for Acurx Pharmaceuticals Inc. forecastingQuarterly Earnings Summary & Precise Buy Zone Identification - Newser
Acurx Pharmaceuticals’ Earnings Call: Optimism Amid Challenges - TipRanks
Published on: 2025-08-31 02:03:09 - Newser
Finanzdaten der Acurx Pharmaceuticals Inc-Aktie (ACXP)
Umsatz
Nettogewinn
Free Cashflow
ENV
Acurx Pharmaceuticals Inc-Aktie (ACXP) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Sailer Carl | Director |
Jan 06 '25 |
Buy |
1.01 |
24,631 |
25,000 |
137,183 |
| LUCI DAVID P | President and CEO |
Jan 06 '25 |
Buy |
1.01 |
49,261 |
50,000 |
1,097,458 |
| Donohue James J. | Director |
Jan 06 '25 |
Buy |
1.01 |
9,852 |
10,000 |
22,352 |
| DELUCCIA ROBERT J | Director |
Jan 06 '25 |
Buy |
1.01 |
49,261 |
50,000 |
1,010,196 |
| DEAN JACK H | Director |
Jan 06 '25 |
Buy |
1.01 |
9,852 |
10,000 |
21,776 |
0.23%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):